Cargando...
β(1)-Blockade increases maximal apnea duration in elite breath-hold divers
We hypothesized that the cardioselective β(1)-adrenoreceptor antagonist esmolol would improve maximal apnea duration in elite breath-hold divers. In elite national-level divers (n = 9), maximal apneas were performed in a randomized and counterbalanced order while receiving either iv esmolol (150 μg·...
Guardado en:
| Publicado en: | J Appl Physiol (1985) |
|---|---|
| Autores principales: | , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
American Physiological Society
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5407199/ https://ncbi.nlm.nih.gov/pubmed/27125844 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/japplphysiol.00127.2016 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|